PharmaCyte Biotech Inc

PMCB.US
Healthcare · Biotechnology
0.59
+0.01 (+0.85%)
USD · NASDAQ

Company Information

Company Name
PharmaCyte Biotech Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US71715X2036
CIK: 0001157075
CUSIP: 71715X203
Currency: USD
Full Time Employees: 2
Phone: 917 595 2850
Fiscal Year End: April
IPO Date: Sep 17, 2010
Description:

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

Address:

3960 Howard Hughes Parkway, Las Vegas, NV, United States, 89169

People

Directors & Officers

Name Title Year Born
Mr. Joshua N. Silverman CEO. President & Executive Chairman 1970
Mr. Carlos A. Trujillo CPA Chief Financial Officer 1958
Dr. Jose L. Iglesias M.D. Consulting Chief Medical Officer 1957
Dr. Hans-Peter Hammes M.D. Member of Medical & Scientific Advisory Board and Consultant NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 07, 2026 Jonathan Schechter N/A Purchase 20.00K $0.84 $16.80K
Jan 07, 2026 Joshua Silverman N/A Purchase 40.00K $0.83 $33.20K
Jan 05, 2026 Jonathan Schechter N/A Purchase 20.00K $0.78 $15.60K
Jan 05, 2026 Joshua Silverman N/A Purchase 30.00K $0.78 $23.40K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Citadel Advisors Llc 359.55K Mar 31, 2026 3.35% $0.00 56.51%
Geode Capital Management, LLC 195.66K Mar 31, 2026 1.82% $0.00 57.99%
Vanguard Group Inc 74.92K Dec 31, 2025 0.70% $0.00 0.00%
Renaissance Technologies Corp 56.50K Mar 31, 2026 0.53% $0.00 -39.92%
XTX Topco Ltd 52.36K Mar 31, 2026 0.49% $0.00 114.23%
Vanguard Capital Management, LLC 51.47K Mar 31, 2026 0.48% $0.00 0.00%
Virtu Financial LLC 37.53K Mar 31, 2026 0.35% $0.00 0.00%
Northern Trust Corp 35.60K Mar 31, 2026 0.33% $0.00 0.00%
Schonfeld Strategic Advisors LLC 27.01K Mar 31, 2026 0.25% $0.00 3.17%
HRT FINANCIAL LLC 24.74K Mar 31, 2026 0.23% $0.00 -86.47%
Vanguard Fiduciary Trust Co 23.45K Mar 31, 2026 0.22% $0.00 0.00%
EQUITEC PROPRIETARY MARKETS, LLC 22.23K Mar 31, 2026 0.21% $0.01 0.00%
SIMPLEX TRADING, LLC 19.94K Mar 31, 2026 0.19% $0.00 -22.81%
TWO SIGMA SECURITIES, LLC 16.36K Mar 31, 2026 0.15% $0.00 -33.37%
Jane Street Group LLC 11.53K Mar 31, 2026 0.11% $0.00 1.22%
Ground Swell Capital, LLC 11.53K Mar 31, 2026 0.11% $0.02 0.00%
Commonwealth Equity Services, LLC 10.31K Mar 31, 2026 0.10% $0.00 0.00%
Tower Research Capital LLC 4.89K Mar 31, 2026 0.05% $0.00 -0.18%
UBS Group AG 4.52K Mar 31, 2026 0.04% $0.00 64.57%
Group One Trading, LLC 1.79K Mar 31, 2026 0.02% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 101.57K 0.95% ▼ 4.44% May 31, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 56.78K 0.53% ▲ 0.00% Jun 30, 2026
3 Fidelity Nasdaq Composite Index 26.21K 0.24% ▲ 0.00% May 31, 2026
4 Northern Trust Extended Eq Market Idx 20.41K 0.19% ▲ 407.79% Mar 31, 2026
5 NT Ext Equity Mkt Index Fund - Lending 20.41K 0.19% ▲ 0.00% Jun 30, 2026
6 Spartan Total Market Index Pool G 20.06K 0.19% ▲ 0.00% May 31, 2026
7 Fidelity Total Market Index 15.26K 0.14% ▲ 0.00% May 31, 2026
8 Fidelity Series Total Market Index 12.90K 0.12% ▲ 0.00% May 31, 2026
9 NT Ext Equity Mkt Index Fund - NL 11.45K 0.11% ▼ 20.63% Jun 30, 2026
10 NT Ext Equity Mkt Idx Fd - DC - NL - T2 8.31K 0.08% ▼ 26.51% Jun 30, 2026

Financial Highlights

Market Cap: $6.28M
PEG Ratio: $0.00
Book Value: $3.59
Earnings/Share: $-0.89
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -6.75%
ROE (TTM): -8.24%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $-13.44M
Trailing P/E: 0.00
Forward P/E: 7.02

Shares Statistics

Shares Outstanding: 10.74M
Shares Float: 9.96M
% Insiders: 574.40%
% Institutions: 901.30%
Short % Float: 3.18%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$0.00
Gross Profit
subtotal
$0.00
SG&A
adjust
$-3.94M
R&D
adjust
$-438.42K
Operating Income
subtotal
$-4.38M
Other / Non-Operating Items
adjust
$35.03M
Net Income
subtotal
$30.66M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PMCB.US!